The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)


Potentially increased incidence of scaffold thrombosis in patients treated with Absorb BVS who terminated DAPT before 18 months

EuroIntervention 2017;13:e177-e184 published online ahead of print May 2017 published online e-edition June 2017. DOI: 10.4244/EIJ-D-17-00119

1. Thoraxcenter, Erasmus Medical Center, Rotterdam, the Netherlands; 2. Maasstad Hospital, Rotterdam, the Netherlands; 3. Albert Schweitzer Hospital, Dordrecht, the Netherlands; 4. National Heart Centre Singapore, Singapore

Aims: The aim of this study was to investigate the impact of dual antiplatelet therapy (DAPT) termination on late and very late scaffold thrombosis (ScT) in patients treated with the Abso

Sign in to read and download the full article

Forgot your password?
No account yet? Sign up for free!
Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from

Read next article
The impact of microvascular resistance on the discordance between anatomical and functional evaluations of intermediate coronary disease